New trial tests if proton therapy can spare brain tissue without hurting survival
NCT ID NCT05190172
First seen May 01, 2026 · Last updated Jun 17, 2026 · Updated 10 times
Summary
This study compares two types of radiation therapy for people with IDH-mutated grade 2 or 3 gliomas (slow-growing brain tumors). The goal is to see if proton therapy, which targets tumors more precisely, is as effective as standard photon therapy at controlling the tumor while causing fewer side effects. About 225 adults aged 18-65 will be randomly assigned to one of the two treatments. The main focus is on survival without needing further treatment at 2 years, along with quality of life and fatigue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGODENDROGLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oslo University Hospital
RECRUITINGOslo, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.